Clinical use of autologous micro-fragmented fat progressively restores pain and function in shoulder osteoarthritis.

Abstract:

:Aim: We aim to show that the use of nondigested micro-fragmented adipose tissue (MFat™, Lipogems®) is a viable alternative for treatment of joint pain and inflammation associated dysfunction in shoulder osteoarthritis (OA). Materials & methods: A total of 25 subjects with OA received an injection of MFat™ and were followed at 6, 18 and 52 weeks intervals. Quantitative analysis of pain and function modalities were performed using the visual analog scale and the disabilities of the arm, shoulder and hand, respectively. Results: All study participants reported significant progressive improvement (p < 0.001) from baseline in visual analog scale and disabilities of the arm, shoulder and hand in shoulder OA cases up to a year post. Conclusion: MFat™ therapy improves pain and function in patients with shoulder OA and can provide a long-term alternative to surgical intervention.

journal_name

Regen Med

journal_title

Regenerative medicine

authors

Vinet-Jones H,F Darr K

doi

10.2217/rme-2020-0069

subject

Has Abstract

pub_date

2020-10-01 00:00:00

pages

2153-2161

issue

10

eissn

1746-0751

issn

1746-076X

journal_volume

15

pub_type

杂志文章
  • Hydrogen sulfide enhances pancreatic β-cell differentiation from human tooth under normal and glucotoxic conditions.

    abstract:AIM:Glucotoxicity obstructs pancreatic differentiation from adult stem cells. The aim was to develop a novel protocol for differentiation of dental pulp stem cells (DPSCs) into pancreatic β cells and determine the effect of H2S on glucotoxicity. MATERIALS & METHODS:DPSCs were differentiated with media containing 5.5 o...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2016-0142

    authors: Matei IV,Ii H,Yaegaki K

    更新日期:2017-03-01 00:00:00

  • Periadventitial adipose-derived stem cell treatment halts elastase-induced abdominal aortic aneurysm progression.

    abstract:AIM:Demonstrate that periadventitial delivery of adipose-derived mesenchymal stem cells (ADMSCs) slows aneurysm progression in an established murine elastase-perfusion model of abdominal aortic aneurysm (AAA). MATERIALS & METHODS:AAAs were induced in C57BL/6 mice using porcine elastase. During elastase perfusion, a de...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.61

    authors: Blose KJ,Ennis TL,Arif B,Weinbaum JS,Curci JA,Vorp DA

    更新日期:2014-01-01 00:00:00

  • Recreating composition, structure, functionalities of tissues at nanoscale for regenerative medicine.

    abstract::Nanotechnology offers significant potential in regenerative medicine, specifically with the ability to mimic tissue architecture at the nanoscale. In this perspective, we highlight key achievements in the nanotechnology field for successfully mimicking the composition and structure of different tissues, and the develo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0120

    authors: Alarçin E,Guan X,Kashaf SS,Elbaradie K,Yang H,Jang HL,Khademhosseini A

    更新日期:2016-12-01 00:00:00

  • Determinants of clinician adoption of regenerative therapies in the UK and Canada: an ophthalmology perspective.

    abstract::The determinants of adoption of regenerative medicine therapies are currently poorly understood. This study aims to draw comparison between the UK and Canada in terms of factors likely to affect healthcare adoption of future regenerative therapies in ophthalmology. Conducting semi-structured interviews with senior oph...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.14.82

    authors: Rose JB,May M,Williams DJ

    更新日期:2015-05-01 00:00:00

  • Biomaterials combined with cell therapy for treatment of spinal cord injury.

    abstract::Spinal cord injury (SCI) is a devastating traumatic injury resulting in paralysis or sensory deficits due to tissue damage and the poor ability of axons to regenerate across the lesion. Despite extensive research, there is still no effective treatment that would restore lost function after SCI. A possible therapeutic ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.121

    authors: Kubinová S,Syková E

    更新日期:2012-03-01 00:00:00

  • New glossary of terms used in regenerative medicine: standardization continues to emerge as regenerative medicine matures.

    abstract::Regenerative medicine is an evolving, cross-disciplinary, international field that, as a result, uses terms that are either not widely understood, or may have a number of different meanings. Many stakeholders have identified this lack of clarity as a potential barrier to effective communication within the field. To ad...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.34

    authors: Sheridan B,Harris N

    更新日期:2009-07-01 00:00:00

  • Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

    abstract::Multipotent mesenchymal stromal cells (MSCs) hold tremendous promise for tissue engineering and regenerative medicine, yet with so many sources of MSCs, what are the primary criteria for selecting leading candidates? Ideally, the cells will be multipotent, inexpensive, lack donor site morbidity, donor materials should...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.10.98

    authors: Wang L,Ott L,Seshareddy K,Weiss ML,Detamore MS

    更新日期:2011-01-01 00:00:00

  • Quality control guidelines for clinical-grade human induced pluripotent stem cell lines.

    abstract::Use of clinical-grade human induced pluripotent stem cell (iPSC) lines as a starting material for the generation of cellular therapeutics requires demonstration of comparability of lines derived from different individuals and in different facilities. This requires agreement on the critical quality attributes of such l...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0095

    authors: Sullivan S,Stacey GN,Akazawa C,Aoyama N,Baptista R,Bedford P,Bennaceur Griscelli A,Chandra A,Elwood N,Girard M,Kawamata S,Hanatani T,Latsis T,Lin S,Ludwig TE,Malygina T,Mack A,Mountford JC,Noggle S,Pereira LV,Pric

    更新日期:2018-10-01 00:00:00

  • Graft and host interactions following transplantation of neural stem cells to organotypic striatal cultures.

    abstract:AIMS:To investigate neural stem cell (NSC) interactions with striatal tissue following engraftment and the effects of growth factors. MATERIALS & METHODS:Organotypic striatal slice cultures established from neonatal rats were used as an ex vivo model system. Survival, integration and differentiation of grafted NSCs fr...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.80

    authors: Jäderstad LM,Jäderstad J,Herlenius E

    更新日期:2010-11-01 00:00:00

  • Implications of multipotent mesenchymal stromal cell aging.

    abstract::Aging is defined as the progressive and generalized impairment of function, resulting in an increasing vulnerability to environmental challenges and a growing risk of disease and death. The decline in the regenerative capacity of resident stem cells across different tissues is a central mediator of aging. In this pape...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.10

    authors: Stochaj U,Kodiha M,Shum-Tim D,Colmegna I

    更新日期:2013-03-01 00:00:00

  • Conference scene. A bright future for tissue engineering and regenerative medicine in the Asia Pacific region.

    abstract::The Tissue Engineering and Regenerative Medicine International Society-Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15-17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia-Pacific region. Several of the plenary lectures focu...

    journal_title:Regenerative medicine

    pub_type:

    doi:10.2217/rme.11.7

    authors: Frith JE,Hudson JE,Cooper-White JJ

    更新日期:2011-03-01 00:00:00

  • The use of hematopoietic stem cells in autoimmune diseases.

    abstract::Hematopoietic stem cells (HSCs) have been shown recently to hold much promise in curing autoimmune diseases. Newly diagnosed Type 1 diabetes individuals have been successfully reverted to normoglycemia by administration of autologous HSCs in association with a nonmyeloablative regimen (antithymocyte globulin + cycloph...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2015-0057

    authors: Ben Nasr M,Bassi R,Usuelli V,Valderrama-Vasquez A,Tezza S,D'Addio F,Fiorina P

    更新日期:2016-06-01 00:00:00

  • Pluripotent stem cells: the last 10 years.

    abstract::Pluripotent stem cells (PSCs) can differentiate into virtually any cell type in the body, making them attractive for both regenerative medicine and drug discovery. Over the past 10 years, technological advances and innovative platforms have yielded first-in-man PSC-based clinical trials and opened up new approaches fo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme-2016-0117

    authors: Kimbrel EA,Lanza R

    更新日期:2016-12-01 00:00:00

  • Functional motor recovery after peripheral nerve repair with an aligned nanofiber tubular conduit in a rat model.

    abstract:AIM:Current synthetic tubular conduits are inferior to nerve autograft for the repair of segmental peripheral nerve injuries. We examined motor outcomes with the use of longitudinally aligned poly (L-lactide-co-caprolactone) nanofiber conduits for repair of nerve gap injury in a rat model. METHODS:Ten-millimeter segme...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.12.87

    authors: Jin J,Park M,Rengarajan A,Zhang Q,Limburg S,Joshi SK,Patel S,Kim HT,Kuo AC

    更新日期:2012-11-01 00:00:00

  • Vascularization in 3D tissue using cell sheet technology.

    abstract::Tissue engineering is a field of study unto itself, but in reality, it is a fusion of medicine, pharmacology, chemistry, cell biology, molecular biology and engineering. The field has been developing at an ever-increasing pace and already provides benefits to regenerative medicine in areas such as the skin and cornea....

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.13.16

    authors: Sekiya S,Shimizu T,Okano T

    更新日期:2013-05-01 00:00:00

  • Short-term outcomes after pure bone marrow aspirate injection for severe knee osteoarthritis: a case series.

    abstract::Background: Bone marrow aspiration (BMA) is among a group of autologous cell-based therapies currently being explored to treat osteoarthritis (OA). Materials & methods: This retrospective case study observed ten patients (13 knees) with severe knee OA who failed extensive conservative treatment and were treated with B...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0113

    authors: Colberg RE,Jurado Vélez JA,Walsh KP,Fleisig G

    更新日期:2020-07-01 00:00:00

  • Biochemical characterization of pure dehydrated binate amniotic membrane: role of cytokines in the spotlight.

    abstract:AIM:Placental allografts used for tissue regeneration differ in membrane compositions and processing techniques. A uniquely folded dehydrated binate amniotic membrane (DBAM) was biochemically characterized to evaluate its potential role in wound healing. METHODS:Histology, Luminex-based immunoassay and standard in vit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2018-0085

    authors: Sane MS,Misra N,Quintanar NM,Jones CD,Mustafi SB

    更新日期:2018-09-01 00:00:00

  • Enhancing medial layer recellularization of tissue-engineered blood vessels using radial microchannels.

    abstract::Aim: Cell repopulation of tissue-engineered vascular grafts (TEVGs) from decellularized arterial scaffolds is limited by dense concentric tunica media layers which impede cells migrating radially between the layers. We aimed to develop and validate a new microneedle device to modify decellularized carotid arteries wit...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0011

    authors: Eufrásio-da-Silva T,Ruiz-Hernandez E,O'Dwyer J,Picazo-Frutos D,Duffy GP,Murphy BP

    更新日期:2019-11-01 00:00:00

  • Therapeutic neutralization of CXCL10 decreases secondary degeneration and functional deficit after spinal cord injury in mice.

    abstract::Inflammation plays a critical role in the secondary degenerative response to spinal cord injury (SCI). The influx of inflammatory cells following SCI is preceded by the expression of specific chemoattractants, including chemokines. The chemokine CXCL10 is a potent T lymphocyte recruiter and has been strongly implicate...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.2.5.771

    authors: Gonzalez R,Hickey MJ,Espinosa JM,Nistor G,Lane TE,Keirstead HS

    更新日期:2007-09-01 00:00:00

  • Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?

    abstract::Dimethyl sulfoxide (DMSO) is the cryoprotectant of choice for most animal cell systems since the early history of cryopreservation. It has been used for decades in many thousands of cell transplants. These treatments would not have taken place without suitable sources of DMSO that enabled stable and safe storage of bo...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0145

    authors: Awan M,Buriak I,Fleck R,Fuller B,Goltsev A,Kerby J,Lowdell M,Mericka P,Petrenko A,Petrenko Y,Rogulska O,Stolzing A,Stacey GN

    更新日期:2020-03-01 00:00:00

  • In vitro potential of human mesenchymal stem cells for corneal epithelial regeneration.

    abstract::Aim: To determine the potential of mesenchymal stem cells (MSC) for corneal epithelial regeneration in vitro. Materials & methods: Bone marrow MSC (BM-MSC) and adipose tissue MSC were analyzed for corneal epithelial and mesenchymal markers, using limbal stem cells and corneal cells as controls. MSC with better potenti...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2019-0067

    authors: Nieto-Nicolau N,Martín-Antonio B,Müller-Sánchez C,Casaroli-Marano RP

    更新日期:2020-03-01 00:00:00

  • Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells.

    abstract:AIM:Dendritic cell (DC)-based vaccines have a potential utility for use in the treatment of malignancy. Human embryonic stem cells (hESCs) may provide a more cost-effective and reliable source of DCs for immunotherapy purposes, providing on-demand access for patients. METHOD:We developed a protocol to generate DCs fro...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.09.25

    authors: Tseng SY,Nishimoto KP,Silk KM,Majumdar AS,Dawes GN,Waldmann H,Fairchild PJ,Lebkowski JS,Reddy A

    更新日期:2009-07-01 00:00:00

  • The emerging landscape of reimbursement of regenerative medicine products in the UK: publications, policies and politics.

    abstract:AIM:This paper aims to map the trends and analyze key institutional dynamics that constitute the policies for reimbursement of regenerative medicine (RM), especially in the UK. MATERIALS & METHODS:Two quantitative publications studies using Google Scholar and a qualitative study based on a larger study of 43 semi-stru...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2017-0041

    authors: Mahalatchimy A,Faulkner A

    更新日期:2017-09-01 00:00:00

  • Development of cell therapy strategies to overcome copper toxicity in the LEC rat model of Wilson disease.

    abstract:AIMS:Therapeutic replacement of organs with healthy cells requires disease-specific strategies. As copper toxicosis due to ATP7B deficiency in Wilson disease produces significant liver injury, disease-specific study of transplanted cell proliferation will offer insights into cell and gene therapy mechanisms. MATERIALS...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/17460751.3.2.165

    authors: Malhi H,Joseph B,Schilsky ML,Gupta S

    更新日期:2008-03-01 00:00:00

  • Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction.

    abstract::In the past decade, stem cell therapy has been increasingly employed for the treatment of various diseases. Subsequently, there has been a great interest in the manufacture of stem cells under good manufacturing practice, which is required by law for their use in humans. The cells for sight Stem Cell Therapy Research ...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme-2015-0020

    authors: Sheth-Shah R,Vernon AJ,Seetharaman S,Neale MH,Daniels JT

    更新日期:2016-04-01 00:00:00

  • In vivo manipulation of stem cells for adipose tissue repair/reconstruction.

    abstract::Many features of adipose stem/progenitor cells, including their physiological functions and localization, have been clarified in the past decade. Adipose tissue turns over very slowly, with perivascular progenitor cells differentiating into new adipocytes to replace dead adipocytes. A number of clinical trials using f...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.11.62

    authors: Yoshimura K,Eto H,Kato H,Doi K,Aoi N

    更新日期:2011-11-01 00:00:00

  • Prospects of stem cell therapy in osteoarthritis.

    abstract::Osteoarthritis is a common disorder in which there is not only extensive degeneration but also an aberrant attempt at repair in joints. Stem cell therapy could provide a permanent, biological solution, with all sources of stem cells (embryonic, fetal and adult) showing some degree of potential. Mesenchymal stromal/ste...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.11.21

    authors: Roberts S,Genever P,McCaskie A,De Bari C

    更新日期:2011-05-01 00:00:00

  • Manufacturing MSCs for commercial application: an interview with Ross Macdonald.

    abstract::Ross Macdonald is the CEO and Managing Director of Cynata Therapeutics Limited (Australia). He has over 30 years of experience and a track record of success in pharmaceuticals and biotechnology businesses. His career history includes positions as Vice President of Business Development for Sinclair Pharmaceuticals Ltd ...

    journal_title:Regenerative medicine

    pub_type: 面试

    doi:10.2217/rme-2019-0122

    authors: Macdonald R

    更新日期:2019-11-01 00:00:00

  • Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.

    abstract::Induced pluripotent stem (iPS) cells offer tremendous opportunity for the creation of autologous cellular therapies, in which gene correction or the avoidance of immune response issues are desirable. In addition, iPS cells avoid the ethical concerns raised by the sourcing of human embryonic stem cells (hESCs) from emb...

    journal_title:Regenerative medicine

    pub_type: 杂志文章

    doi:10.2217/rme.10.55

    authors: Carpenter MK,Couture LA

    更新日期:2010-07-01 00:00:00

  • From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes.

    abstract::Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational intere...

    journal_title:Regenerative medicine

    pub_type: 杂志文章,评审

    doi:10.2217/rme.12.70

    authors: Ricordi C,Inverardi L,Domínguez-Bendala J

    更新日期:2012-11-01 00:00:00